Viemed financial are very strongIt is illuminating to witness the growth for the few quarters and specifically in Q3:
net income $4M USD or $16M USD on annualized basis
e/p = 16M USD / 38M = 0.42 or 0.53 in canadian conversion
I am sure the US market apprciate this type of growth and positive outlook giving it at least a multiple between 25 and 30. In my humble opinion VMD is very very undervalued,waiting for management to higlite plans for 208 and beyond.I allocate a share price of $15.